| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1Department of Neurobiology and 2Committee on Neurobiology, University of Chicago, Chicago, Illinois
Submitted 13 August 2007; accepted in final form 2 October 2007
 |
ABSTRACT |
|---|
|
|
|
INTRODUCTION |
|---|
|
; Gilbert and Franklin 2002; Mitchell et al. 1998; Young et al. 1984). Morphine acts on two physiological classes of RM neurons that were originally defined by their physiological responses to noxious stimulation and morphine. ON cells in RM are excited by noxious cutaneous stimulation and inhibited by opioids administered either centrally or peripherally (Barbaro et al. 1986; Fields et al. 1983a). In contrast, RM OFF cells are inhibited by noxious cutaneous stimulation and excited by analgesic doses of central or peripheral opioids (Barbaro et al. 1986; Fields et al. 1983a,b). Because the background firing rates of ON and OFF cells correlate, inversely and proportionately, respectively, with the level of analgesia across a wide range of conditions, ON cells are thought to facilitate nociceptiON and OFF cells to suppress nociception (Fields et al. 1991). This physiological model has proved of great heuristic value, spawning a multitude of experiments whence new insights into the mechanisms of both analgesia and persistent pain have emerged (Hurley and Hammond 2000, 2001; Meng et al. 1998; Porreca et al. 2002). Yet this model of medullary pain modulation is founded entirely on electrophysiological and microinjection studies in rats. To enable the use of mouse genetics to further our understanding of RM's role in pain modulation, we have tested whether three fundamental findings observed in rats also occur in mice: opioid microinjection into RM produces antinociception (Fang et al. 1989; Hurley and Hammond 2000; Jones and Gebhart 1988); the response of RM cells to noxious stimulation predicts the response to opioid analgesic administration; and the discharge of murine RM cells predicts nociceptive responsiveness (Foo and Mason 2003b; Heinricher et al. 1989; Jinks et al. 2004).
In addition to participating in pain modulation, studies in rat demonstrate that RM contributes to normal physiological functioning (for review, see Mason 2001; Nakamura et al. 2005; Richerson 2004). In the rat, RM neurons project oligosynaptically to all sympathetic and parasympathetic targets tested to date as well as to somatic targets involved in micturition, breathing, and escape (Cao et al. 2006b; Kerman et al. 2003; Mason 2005; Nadelhaft and Vera 1996, 2001). Although some have argued that RM cells mediate specific physiological functions such as cold defense or fever (Blessing and Nalivaiko 2000; Morrison et al. 1999; Nakamura et al. 2004; Rathner et al. 2001; Tanaka et al. 2006), the multitude of pathways from RM neurons to widespread targets as well as pathways from some individual RM neurons to multiple targets (Jansen et al. 1995; Nadelhaft and Vera 2001) make unlikely that RM is involved in only a single, specific physiological function (for review, see Mason 2005). Consistent with the idea that RM modulates many physiological functions, opioid microinjections into the rat RM alter cold defense, micturition, and locomotion as well as nociceptive behavior (da Silva and Menescal-de-Oliveira 2007; Morgan and Whitney 2000; Nason and Mason 2006; York et al. 2005). Further, RM lesions in the rat block intestinal paralysis evoked by opioid administration into the midbrain periaqueductal gray (Parolaro et al. 1985) as well as cardiovascular responses evoked by systemic morphine (Randich et al. 1992). To examine the role of the murine RM in physiological homeostasis (Craig 2003), we tested whether opioid microinjection into the murine RM alters cardiorespiratory activity and whether the discharge of murine RM cells predicts spontaneous changes in cardiorespiratory function. Finally, complementary experiments in the rat permitted a direct comparison of RM function and physiology in rat and mouse.
|
|
METHODS |
|---|
|
Male C57BL/6 (n = 70, 20–28 g; Charles River, Portage, MI) and DBA (n = 5, 20–25 g) mice were anesthetized with 5% isoflurane. Anesthesia was maintained by 1.2–1.6% isoflurane throughout the duration of the surgery. Core temperature was maintained with a water-perfused heating pad. In experiments with intracerebroventricular injections, an additional craniotomy was made over the right lateral ventricle. Needle electrodes were placed into the thorax bilaterally to record the electrocardiogram (EKG) and into the biceps femoris to record the electromyographic activity (EMG) of the hindlimb withdrawal muscles. In some animals, screw electrodes were inserted into the skull over the parietal region to record electroencephalographic activity (EEG). A 1-mm-diam craniotomy was made 1–2 mm caudal from lambda to allow for access to RM. After surgery, animals were given 1 h to allow the animal to equilibrate to 1.0% isoflurane (Eger 1984).
Drugs
Morphine sulfate (Malinckrodt, St. Louis, MO) and d-Ala2, N-Me-Phe4-Gly5ol-enkephalin (DAMGO; Multiple Peptide Systems, San Diego, CA) were dissolved in phosphate-buffered saline (PBS). Naloxone hydrochloride was purchased already dissolved in saline (0.4 mg in 1 ml, Abbott Laboratories) and administered intraperitoneally in rats but subcutaneously in mice because of the large volume.
Electrophysiological methods
Tungsten metal electrodes (5 M
, A-M Systems, Pullman, WA) were lowered at a 0–10° angle (2.0–3.0 mm posterior from lambda, 0.0–0.5 mm lateral, 5.0–6.0 mm ventral from cerebellar surface) into the region of the RM. The unit waveform was acquired at 40 kHz by a CED Micro1401 interface (CED, Cambridge, UK), and spikes were sorted off-line using template matching. Locations of all recorded neurons were marked with lesions by passing 20 µA anodal current for 4 min.
Neuronal characterization
Cells were characterized by their responses to at least three trials of noxious paw heat applied using a Peltier device (Yale Instrumentation, New Haven, CT). The heat stimulus consisted of a 1.9-s ramp from 32 to 51°C with a 4.5-s plateau at the peak temperature. The Peltier platform then ramped back down to 32°C over the course of 1.8 s. The footpad and toes of the hindpaw were affixed, using Velcro straps, to the Peltier platform (2 cm square) so that they were exposed to the full-duration stimulus. Between stimuli, the Peltier platform was maintained at 32°C. Although evoked withdrawals in mice and rats were similar, an interstimulus interval of 500 s was necessary to prevent withdrawal fatigue in the mouse, whereas an interval of 300 s was sufficient in the rat.
Neurons that were successfully isolated and demonstrated either an excitatory or inhibitory response to noxious stimulation were investigated further, thus biasing the sample to ON and OFF cells. Because our initial electrophysiological experiments resulted in only seven OFF cells, we recorded from an additional eight mice with the specific intention of increasing the sample of OFF cells. In these additional experiments, we tried to reduce the surgical time and anesthetic exposure, both of which appear to suppress OFF cell firing. To this end, we omitted putting in an intracerebroventricular cannula and were thus able to record an OFF cell in each additional experiment.
Morphine administration and cell recording
After characterization of a cell, as described in the preceding text, morphine was administered after which paw heat trials continued at 500-s intervals. After at least three trials of paw heat were recorded postmorphine administration, additional dosages of morphine or naloxone hydrochloride were injected and followed by more trials of heat stimulation.
DAMGO microinjections into RM
Mice were prepared with a guide cannula (Plastics One, Roanoke, VA) into RM as well as with EMG electrodes as in the preceding text. After equilibration at 1.0% isoflurane, three paw heat trials were applied at 500-s intervals. DAMGO was then injected into RM or dorsally as a placement control. Paw heat trials continued to be applied at 500-s intervals after microinjections. After at least three postinjection trials had been collected, naloxone (0.4 mg/1 ml saline sc) was administered, and again paw heat trials were applied at 500-s intervals. In four mice, saline (500 nl) was injected prior to DAMGO injection, and another four mice received saline followed by naloxone. The injection cannula was left in place until the conclusion of the experiment when it was withdrawn and filled with either India ink or Pontamine Sky blue. The dye-filled injector was placed back into the guide cannula and an injection of 500 nl was made to mark the microinjection site.
Histology
Animals were overdosed with 5% isoflurane and 10 mg pentobarbital and perfused with a fixative containing 4% paraformaldehyde and 7% sucrose in 0.1 M PBS. The brain stem was removed, postfixed for 24 h, and then immersed in 30% sucrose in 0.1 M PBS. Coronal sections (50 µm) were cut on a freezing microtome. Sections were mounted on gelatin-coated slides and then stained with cresyl violet. Microinjection and lesion sites were identified and drawn under x50 magnification. Sites were assigned an anterior-posterior location and then plotted on standard sections adapted from Fig. 2 of VanderHorst and Ulfhake (2006). In the mouse, RM included a region 600 µm wide centered on the midline to a point 1,000 µm dorsal to the base of the brain. The nucleus reticularis magnocellularis (NRMC), adjacent to RM, which is termed nucleus reticularis gigantocellularis pars alpha by some, was considered to encompass regions located 300–600 µm on either side of the midline and from the ventral surface to a point 1,000 µm dorsal to the base of the brain. The anterior and posterior borders of RM and NRMC were the first section caudal to the nucleus of the trapezoid body and the first section rostral to nucleus ambiguous, respectively. Sites superficial to RM and NRMC that were located between the lateral edges of the pyramids were considered to be in nucleus reticularis gigantocellularis (NRGC). Neurons outside of RM and NRMC are not included in this report. DAMGO injections outside of RM and NRMC are considered as placement controls (see following text).
|
Although cells with a slow and regular pattern of discharge that are highly likely to be serotonergic (Li and Bayliss 1998; Mason 1997; Wang et al. 2001) were not studied, an algorithm that physiologically identifies serotonergic and nonserotonergic cells was employed to gain further confidence that studied cells were indeed nonserotonergic (Mason 1997).
A previously described statistical algorithm was used to classify cells as ON, OFF, or NEUTRAL (Leung and Mason 1998). Briefly, the SD of the change in discharge rate across sequential 10-s bins was calculated from a 500-s period without stimulation. Evoked changes were considered significant if they exceeded a threshold defined as two times this SD. Using this criterion, responses were determined, and then cells were classified as ON or OFF if they were excited or inhibited, respectively, in a majority of stimulation trials and as NEUTRAL if they did not respond consistently.
Mean background discharge rate for each cell was calculated from the 60 s prior to each paw heat trial. Evoked discharge was defined as the mean discharge rate during ("stim") or after ("post") each paw heat trial less the background discharge rate. Then for each cell, values from multiple paw heat trials for each variable (background, evoked stim, evoked post) were averaged during baseline, post-DAMGO, -saline, and -naloxone periods. Population means, calculated for ON and OFF cells during baseline and postdrug periods, were compared between groups using an ANOVA followed by post hoc comparisons using Newman-Keuls.
EEG analysis
EEG recordings were conducted on a subset of the mice receiving microinjections. The EEG was analyzed with a fast Fourier transform on a 64-s window (256 Hz, 214 points). Delta activity was the power summed within the frequency range of 1–4 Hz. To determine the effect of opioids on cortical activity, artifact-free periods of 500 s before and after DAMGO (excluding electrical artifact produced by movement of the microinjection cannula) and naloxone, during which no stimuli were applied, were analyzed as above for delta activity and compared between groups using an ANOVA.
Analysis of physiological reactions
Heart rate was calculated as the reciprocal of the interval between successive R waves in the EKG. The EKG signal was then high-pass filtered to eliminate the slow QRS waves. The remaining fast EMG activity, reflective of intercostal muscle activity, was full-wave rectified and integrated. From this processed signal, respiratory rate was calculated as the reciprocal of the interval between successive peaks (each peak marking inspiration).
Preheat trial heart and respiratory rates were considered baseline variables. For each of these variables, the mean values for the 60 s prior to each paw heat trial were calculated. Then for each animal, the mean values before and after each drug were calculated. Finally, population means for each experimental group were calculated and compared between groups using an ANOVA.
The hindlimb EMG recording was full wave rectified and integrated. Evoked withdrawal magnitude was quantified as the sum of the EMG for 8.2 s (the full duration of the heat stimulus) after stimulus onset less the sum for 8.2 s prior to the stimulus. The onset of the evoked withdrawal was determined by the time when the amplitude of the EMG exceeded 2 SD above the mean, prestimulus EMG activity. For each trial and each experimental group, mean withdrawal magnitude and latency were calculated and then compared between groups using an ANOVA.
Correlational analyses
For each cell, the mean withdrawal latency, peak magnitude, and integrated magnitude and the mean cellular response to each heat trial during the baseline period were calculated. All variables were normalized by a Z-score transformation. Briefly the Z score is equal to (R – X)/SD where R is the variable from an individual trial, X is the mean variable from the animal (for withdrawal variables) or cell (for cell discharge), and SD is the SD of that variable for all trials in the animal or cell. This transformation compensates for variability between animals and neurons. A correlation analysis was then conducted between cellular discharge, during different epochs (as described in RESULTS), and all variables of the withdrawal reaction.
To determine the relationship between RM cell discharge and brief episodes of tachypnea, an automatic search program identified increases in respiratory rate that exceeded 5%. The search program computed the average respiration rate in rolling (100-ms advancing interval) 30-s time bins. Tachypneic episodes were then defined as events when the second bin's average exceeded the first bin's average by 5%. For every tachypneic event, the average cell activity, heart rate, and respiration rate were calculated for both time bins with the first bin representing baseline and the second bin considered tachypnea.
Rat experiments
Most experiments on male Sprague–Dawley rats (n = 20, 250–500 g; Charles River, Portage, MI) were reported in Brink et al. (2006). The experimental protocol in these rat studies was similar to that in the mouse studies with the following exceptions: rats were anesthetized with halothane, an arterial catheter was placed in the femoral artery, rats received intermittent colorectal distension stimulation, and DAMGO (50 ng) rather than morphine was administered intracerebroventricularly. Additionally, previously unpublished experiments in rats (n = 12) examining the effect of 0.5 mg im morphine on RM cellular activity are also included. Of note, in the former experiments, two to four electrodes were inserted together, resulting in the simultaneous recording of multiple single units in each animal.
Statistics
Each variable is expressed as a mean ± SE. Statistical tests were performed using SigmaStat (SPSS Science, Chicago, IL). For multiple comparisons, repeated-measures ANOVA with Bonferonni corrections were performed. Pearson correlations were calculated to test the relationship of firing rates with withdrawal parameters using Z-score normalization to account for variability between subjects. All P values >0.001 are reported exactly and those <0.001 are noted as "P < 0.001." A P value <0.05 was considered significant.
|
|
RESULTS |
|---|
|
DAMGO microinjection into RM (50 ng, 500 nl) significantly increased the latency (P = 0.003) and reduced the magnitude (P = 0.05) of withdrawals from noxious paw heat in lightly anesthetized mice (n = 11, Fig. 1). Subsequent naloxone administration (0.4 mg, 1 ml sc) significantly decreased the withdrawal latency of mice that had received DAMGO (P = 0.03, n = 11). Saline microinjection into RM (n = 8) or DAGMO microinjection into the dorsally located NRGC (n = 6) had no effect on withdrawal latency (saline P = 0.72, NRGC P = 0.19) or magnitude (saline into RM: P = 0.42; DAMGO into NRGC P = 0.50).
|
Hypothesizing that the observed cardiorespiratory depression reflected a change in arousal state, EEG recordings were performed on mice receiving DAMGO in RM (n = 8), saline in RM (n = 6), or DAMGO in NRGC (n = 4). An overall "flattening" of the EEG after DAMGO administration into RM was visible to the experimenter even prior to FFT analysis. Indeed, delta activity, a measure of synchronized slow cortical activity, decreased after DAMGO administration into RM (Fig. 1; P = 0.03). Although a decrease in delta power implies a heightened level of arousal (Grahn and Heller 1989), mice were simultaneously less responsiveness to noxious stimuli. No significant effect on delta power was observed when saline was microinjected into RM (P = 0.91) or when DAMGO was microinjected into NRGC (P = 0.25).
Background discharge and heat-evoked responses of murine RM cells resemble those of rat RM cells
Each neuron was characterized by its resting discharge and response to noxious stimulation (Fig. 2 ). Only cells located in RM (n = 42) or the adjacent NRMC (n = 15) were studied (Fig. 3). Although we intended to study only cells that were excited or inhibited by a heat stimulus, post hoc analysis revealed that some cells did not respond consistently to heat stimuli and thus were classified as NEUTRAL (n = 6). No neurons had the slow and steady discharge characteristic of serotonergic neurons in the rat (Mason 1997) or cat (Auerbach et al. 1985). In 49 of 57 neurons recorded, the coefficient of variation (CV) of the interspike interval was >1, indicating a discharge that includes bursts and frank pauses (CV = 5.6 ± 0.8, firing rate = 12.7 ± 2.6 Hz). The remaining eight neurons with a CV < 1 were unlikely to be serotonergic because they all had firing rates that exceeded 10 Hz. As previously observed in rats, more cells were excited (ON cells, n = 32, Fig. 2A) than inhibited (OFF cells, n = 15, Fig. 2B) by noxious heat. We often (10–25% of all cell encounters) encountered cells that appeared to respond to noxious heat only after the stimulus had ended but only characterized a few such neurons that were clearly inhibited (n = 3 cells) or excited (n = 1 cells) after the offset of the heat stimulus (data not shown); these cells are not included in the analysis in the following text.
|
and METHODS for details). To compare the noxious heat-evoked responses of cells from rat and mouse, all responses were normalized to this response threshold so that, for example, a change in discharge that is threefold greater than the response threshold was assigned a value of 3.0. This analysis revealed two significant differences. First, the decrease in OFF cell discharge during heat stimulation was greater in rat (3.1 ± 0.8) than in mouse (1.4 ± 0.1; P = 0.04). Second, 1 min after stimulation, ON cell discharge was still greater than threshold in rat (2.5 ± 0.4) but not in mouse (0.4 ± 0.3; P < 0.001). In both mouse and rat, background discharge and heat-evoked responses were greater in animals receiving intramuscular injections than in those receiving intracerebroventricular injections. These differences were likely due to the additional anesthetic exposure and surgery endured by the latter animals. Moreover, differences in the numbers of rats and mice receiving systemic and central injections cannot account for the greater responses of ON cells in rats relative to mice as more rats received intracerebroventricular injections and more mice received systemic injections. ON cells' responses to noxious stimulation, but not background firing rates, were reduced by an analgesic dose of morphine
A comparison between the effects of identical opioid doses, in grams per body weight, on RM cells in mouse and rat would be inappropriate as the doses required to produce analgesia are 10–100 times greater in mouse than in rat (Mogil and Wilson 1997; Mogil 1999; Szekely et al. 1984). Therefore we decided to compare low doses that produce reliable analgesia. For rats, doses were chosen from the literature to avoid using animals to reconfirm well-established findings. The doses were 500 µg (
1.25 mg/kg based on the average weight of rats used, 400 g) of systemic morphine (Tyler and Advokat 1986) and 50 ng (125 ng/kg) of intracerebroventricular DAMGO (Kepler et al. 1991). For mice, a series of doses were tested. As illustrated in Fig. 4, 500 µg (n = 20; 20 mg/kg, based on the average weight of mice used, 25 g) but not 100 µg (n = 5; 4 mg/kg) of systemic morphine produced analgesia in mice; therefore the effect of a 500 µg dose of systemic morphine on murine RM cell firing was tested. When administered intracerebroventricularly, 10 µg (n = 7; 40 µg /kg) but not 5 µg (n = 5; 20 µg /kg) DAMGO significantly increased the paw withdrawal latency (Fig. 4B). The effect of 10 µg icv DAMGO was then tested on the discharge of RM cells in mice.
|
|
Morphine's failure to reduce the background discharge of ON cells in the murine RM is in sharp contrast to the significant reduction of ON cell background discharge by opioid receptor agonists in rats (Barbaro et al. 1986; Brink et al. 2006). To ensure that there was nothing in the experimental setup preventing us from seeing a more typical (for the rat) ON cell response to opioids, morphine's reduction of rat ON cell discharge was confirmed here in a set of experiments. The background, heat-evoked, and poststimulus discharge rates of rat ON cells decreased after systemic morphine (n = 8; P < 0.05; Fig. 6B) or intracerebroventricular DAMGO (n = 27; P < 0.01; Fig. 6D). An analysis of individual cell responses showed that the discharge rate of all rat ON cells tested (n = 8) decreased after systemic morphine and nearly all ON cells in the rat (25/27) were similarly inhibited by intracerebroventricular DAMGO.
|
The activity of 12 murine OFF cells was recorded in response to morphine. In 10 mice receiving systemic injections, there was no consistent effect of 0.5 mg morphine on OFF cell background firing rate (P = 0.96) despite consistent increases in withdrawal latency (P < 0.01) (Fig. 7). Although two individual OFF cells were significantly excited by morphine, another two OFF cells were inhibited. Even when an additional dosage of 1 mg morphine was injected in four cases, there was no observable excitation of OFF cells. In the case of two OFF cells, intracerebroventricular morphine significantly decreased background firing rate.
|
2 SD by intracerebroventricular DAMGO (6/9 cells) and intramuscular morphine (4/4 cells). Even in the three rat OFF cells the discharge of which was not significantly increased by 2 SD, there were nonetheless long-lasting increases in firing rate. Prestimulus ON cell activity does not correlate with the magnitude of withdrawal in mouse
Because reduction of background ON cell activity is a primary effect of opioid drug administration in rats but not mice, we anticipated that there may be an additional difference between rats and mice in the relationship of ON cell activity to withdrawal magnitude even in the absence of morphine. To test whether ON cells modulate future noxious stimulus-evoked withdrawals, ON cell activity was correlated to the magnitude of withdrawals in the baseline condition (all variables were transformed to Z scores as described in METHODS). The data set contained recordings of neurons paired with withdrawals in mice (32 neurons, 137 withdrawals) and rats (31 neurons, 125 withdrawals).
In mice, there were no significant correlations between firing rate prior to withdrawal and the parameters describing the ensuing withdrawal (Fig. 8). In rats, firing rates during the 15-s and 1-min periods prior to withdrawal correlated with peak EMG amplitude (–1 min: r2 = 0.05, P = 0.01; –15 s: r2 = 0.07, P = 0.003) and withdrawal latency (–1 min: r2 = 0.04, P = 0.02; –15 s: r2 = 0.07, P = 0.002) but not with integrated EMG amplitude (–1 min: r2 = 0.01, P = 0.43; –15 s: r2 = 0.01, P = 0.43). We also examined the relationship between firing rate and the concurrent withdrawal. In mice, the firing rate during noxious stimulation was significantly correlated with two measures of withdrawal strength: peak EMG amplitude (r2 = 0.03, P = 0.04) and withdrawal latency (r2 = 0.03, P = 0.02). In rats, there were correlations between evoked firing rate and all three parameters describing withdrawals (r2 > 0.06, P < 0.005). In sum, the background discharge of rat ON cells significantly predicted ensuing withdrawal strength, but the background discharge of murine ON cells did not. Further, the noxious heat-evoked discharge of both murine and rat ON cells correlated significantly with the simultaneously occurring withdrawal reaction.
|
Given the poor correlation of background activity in mice to withdrawal magnitude, we visually examined the records to find other factors that might correlate with ON cell firing. We observed that transient increases in respiration rate often occurred around the time of bursts of ON cell activity (Fig. 9). To examine the consistency of this relationship, we identified all transient increases (5%) in respiration rate that were not evoked by a noxious stimulus (see METHODS) and then analyzed ON cell firing rates during these events. ON cell firing rates increased by 9.0 ± 1.9 Hz (P < 0.001, n = 20) during transient episodes of tachypnea (Fig. 10). During these periods there were no changes in heart rate (P = 0.39) or EMG tone (P = 0.57). We also performed the reverse analysis to see if periods of increased ON cell activity were related to increases in respiration rate. Periods of unstimulated, but increased ON cell activity (n = 30) were associated with a 7.5% increase in respiration (P < 0.001) but not with alterations in heart rate (P = 0.87) or EMG tone (P = 0.31).
|
|
|
|
DISCUSSION |
|---|
|
The first goal of this study was to test whether findings basic to RM's role in nociceptive modulation are observed in mouse as they are in rat in order that the pain modulation field could, with good reason, employ the mouse as a close analog of the rat. The unfortunate answer appears to be that the participation of RM in nociceptive modulation in the mouse differs in basic ways from that in the rat. Most importantly, the response of RM murine cells to noxious cutaneous stimulation does not predict the response to opioids as is true in the rat. Because this is the fundamental basis of the heuristic model developed by Fields, prudent researchers will not simply extend the rat ON–OFF cell model to mice.
The second aim of this study was to determine whether the murine RM participates in modulation of physiological processes beyond nociception. The clear answer is yes. However, because we only tested RM's modulation of heart rate, respiration rate, and cortical synchrony, more studies are needed to determine the full range of physiological functions that RM modulates.
At first glance, the differences between male Sprague-Dawley rats and male C57BL/6 mice would appear to be due to a distinction between rats and mice. However, it should be noted that Sprague-Dawley is the strain used in all of the physiological studies of RM known to the authors. Although results from the few DBA mice that we studied were not notably different from those obtained from C57BL/6 mice, a preliminary study has reported differences in the effects of DAMGO on the noxious stimulus-evoked responses of RM neurons in CBA/J and A/J mice (Sugino et al. 2006). Thus the differences observed may reflect either a true species difference or alternatively, a difference between strains that also happen to come from different species.
Murine RM contributes to opioid analgesia but not through a change in the background activity of ON and OFF cells
DAMGO microinjection into the murine RM increases the latency and reduces the magnitude of noxious heat-evoked withdrawals, evidence that the RM plays a role in nociceptive modulation. However, in contrast to the case in the rat, the background activity of murine ON cells—RM cells excited by noxious cutaneous stimulation—was not inhibited by opioids and that of murine OFF cells—RM cells inhibited by noxious cutaneous stimulation—was not excited by analgesic doses of opioids. Thus murine RM ON and OFF cells mediate opioid analgesia differently than do the much more widely studied rat RM cells.
The lack of a correspondence between murine RM cells' responses to noxious heat and opioids was not due to any peculiarity in our experimental setup as we confirmed just such a correspondence in recordings from a cohort of rats. It is possible that we did not record from a sufficient number of cells or from cells in the right location in the mouse. However, this is unlikely as recordings from rat clearly confirmed that ON cells are inhibited and OFF cells excited by opioids. Beyond the significance of the rat ON and OFF cell populations' responses to opioids and the lack of significance in the murine populations' responses to opioids, 30 of 35 rat neurons responded to an analgesic opioid dose in the canonical way, whereas only 5 of 39 murine cells responded in this manner. Further, the murine neurons recorded were made in the same region where opioid microinjection produced antinociception. Thus it is unlikely that ON cell inhibition and OFF cell excitation play the same integral role in opioid analgesia in mouse as they do in rat.
Opioids' failure to alter the background firing rates of RM cells in the anesthetized mouse resembles findings obtained in awake rats, where background ON cell firing rates are not affected by morphine (Martin et al. 1992). Thus although studies in the anesthetized rat have focused on the effect of opioids on spontaneous RM ON cell activity rather than on evoked activity (Anderson et al. 1977; Azami et al. 1979; Barbaro et al. 1986; Chiang and Gao 1986; Chiang and Pan 1985; Deakin et al. 1977; Fields et al. 1983a,b; Heinricher and Rosenfeld 1985; Satoh et al. 1979; Schnell et al. 2002; Toda 1982), it is clear that alterations in the spontaneous activity of RM ON cells are not essential for opioid analgesia in awake rats or anesthetized mice.
Critical function of RM may be to modulate the size of on-going, rather than future, protective motor reactions
Opioids did not alter the background firing but did suppress the noxious stimulus-evoked responses of murine RM ON and OFF cells. Similarly, a recent preliminary study reported that DAMGO suppressed the noxious stimulus-evoked responses of RM neurons from two different strains of mice (Sugino et al. 2006). This profile of opioid responses in the anesthetized mouse resembles that described in the unanesthetized rat. In the only study to test the opioid responses of cells with known responses to noxious stimulation in the awake rat, background ON cell firing rates were not affected by morphine, but ON cell responses to noxious stimulation were reduced (Martin et al. 1992).
Here we found that the relative latency and magnitude of withdrawals were not predicted by the rate at which ON cells fire prior to the noxious stimulus in the mouse. As a positive control, we were able to confirm previous studies (Foo and Mason 2003b; Heinricher et al. 1989) that this predictive relationship exists in the rat. The amount of murine ON cell discharge during noxious stimulation did correlate with the magnitude and latency of the withdrawals evoked concurrently, suggesting that the murine RM modulates withdrawals as they are occurring rather than withdrawals that are about to occur. Findings that RM neurons respond after the onset of the disynaptic jaw-opening reflex and after the onset of laser stimulus-evoked withdrawals further support this conclusion (Foo and Mason 2003; Mason et al. 1986).
Although initially difficult to reconcile with a literal interpretation of Fields' original model of RM ON and OFF cell function, our current findings fit with the more extensive literature arising from experiments in anesthetized rats. First, our finding that DAMGO microinjection into the murine RM suppresses nociceptive withdrawals shows that the RM has the capacity to modulate nociceptive transmission in mouse as well as in rat and cat (Oliveras et al. 1975; Sessle and Hu 1981). Second, our finding that ON cell responses to noxious stimulation correlate with the withdrawals evoked concurrently fits with a role for RM in modulating the magnitude of protective reactions to visceral and somatic stimuli. Just such a role has been documented in the somatomotor reaction to colorectal distension (Brink and Mason 2004) and the withdrawals evoked by cutaneous stimulation in the territory of an injured nerve (Burgess et al. 2002; Porreca et al. 2001). If this proves a consistent finding in rats and mice, anesthetized and unanesthetized, then modulating the size of on-going protective motor reactions may be a fundamental function of RM.
RM is important in regulation of physiological processes beyond nociception
Opioid microinjection into the murine RM evoked bradycardia and bradypnea. Widespread oligosynaptic pathways from RM neurons to most viscera and glands including heart (Ter Horst et al. 1996), cutaneous arteries (Smith et al. 1998), lungs, and trachea (Hadziefendic and Haxhiu 1999; Haxhiu et al. 1996) as well as to breathing muscles including the diaphragm (Billig et al. 2000; Yates et al. 1999) provide an anatomical substrate for the influence of RM on heart rate and respiration rate.
DAMGO microinjection into RM caused the murine EEG to change from a state resembling a deep sleep stage IV to a state akin to the lighter sleep stage I/II (Rechtschaffen and Kales 1968) at the same time as responses to noxious stimuli were delayed. This coupling of cortical arousal and reduced responsiveness to noxious stimulation is consistent with morphine's strong sedative (lowered responsiveness to external stimulation) but weak hypnotic (sleep-producing) effects (Kay 1975; Kay et al. 1979; Shaw et al. 2005). Previous studies have demonstrated that chemical microinjection into RM can modify cortical state with bicuculline reducing the time spent awake after an innocuous stimulus (Foo and Mason 2000, 2003a) and lidocaine producing arousal (Berner et al. 1999). Consistent with RM's role in cortical state modulation, RM cells in the rat change their activity at transition points between EEG states in both anesthetized (Grahn and Heller 1989) and unanesthetized animals (Leung and Mason 1999). Finally, RM cells have been implicated in the suppression of somatic inputs during sleep (Foo and Mason 2003a; Leung and Mason 1999; Mason et al. 2001). An increase in arousal during times of reduced sensitivity to external stimulation is adaptive as it provides a method for cognitive protection during a period of vulnerability.
The specific physiologic variables measured in this study were chosen primarily because they could be recorded with minimally invasive methods. Yet it is unlikely that RM's modulatory targets are restricted to those measured. Instead the measured changes in cardiorespiratory function and cortical activity are likely emblematic of a widespread modulatory influence exerted by RM on homeostatic physiological functions. Certainly, oligosynaptic pathways exist, at least in the rat, from RM to every autonomic and respiratory target tested (see preceding text). Thus although our data are direct evidence that the murine RM has the capacity to simultaneously modulate nociception, cardiovascular function, breathing, and behavioral state, the physiological processes targeted by RM are unlikely to be restricted to the studied functions.
RM may modulate respiration and mediate morphine-induced respiratory depression
The respiratory depression produced by DAMGO microinjection into the RM and the power of RM cell firing to predict tachypneic events implies a specific role for the murine RM in respiration. Studies in the rat have noted that electrical stimulation of or glutamate microinjection into RM produces apnea (Aoki and Nakazono 1992; Cao et al. 2006a; Lalley 1986; Wang et al. 1988), whereas bicuculline microinjection increases respiration rate (Nason and Mason 2004). RM neurons project to the phrenic motor nucleus (Cao et al. 2006b). Our results complement these findings by showing that ON cell bursts predict spontaneous episodes of tachypnea. Further, the association of tachypnea with ON cell bursts and OFF cell pauses suggests that RM cells contribute to generating tachypnea. The possibility also exists that ON cell quiescence and OFF cell firing contributes to opioid respiratory depression. In mice, the highest doses of systemic morphine (1 mg) decreased background ON cell activity and respiratory rate. In sum, the reduction in respiratory rate caused by DAMGO microinjection into RM and the predictive relationship of RM cell discharge on respiratory activity imply that the RM participates in respiratory depression induced by high doses of morphine as well as in on-going respiratory modulation.
Similarities between RM physiology in mouse and rat provide insight into the core functions of the medullary raphe
The function of the murine RM resembles the rat RM in two key respects. First, RM cells modulate protective on-going withdrawals. Focusing modulation on on-going rather than future withdrawals allows the initial reflex withdrawal to occur while also providing flexibility in regulating the duration and magnitude of the complete reaction. Second, RM modulates a number of physiological functions beyond nociception. These two features, present in both rat and mouse, are core to RM's function.
|
|
GRANTS |
|---|
|
|
|
ACKNOWLEDGMENTS |
|---|
|
Present address of T. S. Brink: University of Minnesota, School of Dentistry, Dept. of Diagnostic and Biological Sciences, 515 Delaware St SE 17-252 Moos Tower, Minneapolis MN 55455.
|
|
FOOTNOTES |
|---|
Address for reprint requests and other correspondence: P. Mason, Dept. of Neurobiology, University of Chicago, MC 0928, 947 East 58th St., Chicago, IL 60637 (E-mail: p-mason{at}uchicago.edu)
|
|
REFERENCES |
|---|
|
Aoki M, Nakazono Y. Raphe magnus-induced inhibition of medullary and spinary respiratory activities in the cat. In: Control of Breathing and its Modeling Perspective, New York: Plenum, 1992, p. 15–23.
Auerbach S, Fornal C, Jacobs BL. Response of serotonin-containing neurons in nucleus raphe magnus to morphine, noxious stimuli, and periaqueductal gray stimulation in freely moving cats. Exp Neurol 88: 609–628, 1985.[CrossRef][Web of Science][Medline]
Azami J, Llewelyn MB, Roberts MH. The contribution of nucleus reticularis paragigantocellularis and nucleus raphe magnus to the analgesia produced by systemically administered morphine, investigated with the microinjection technique. Pain 12: 229–246, 1982.[CrossRef][Web of Science][Medline]
Azami J, Roberts MH, Wright DM. Effects of ionophoretic application of morphine and naloxone on responses of nucleus reticularis paragigantocellularis neurones to noxious stimulation in the rat. J Physiol 293: 63P–64P, 1979.[Medline]
Barbaro NM, Heinricher MM, Fields HL. Putative pain modulating neurons in the rostral ventral medulla: reflex-related activity predicts effects of morphine. Brain Res 366: 203–210, 1986.[CrossRef][Web of Science][Medline]
Berner NJ, Grahn DA, Heller HC. 8-OH-DPAT-sensitive neurons in the nucleus raphe magnus modulate thermoregulatory output in rats. Brain Res 831: 155–164, 1999.[CrossRef][Web of Science][Medline]
Billig I, Foris JM, Enquist LW, Card JP, Yates BJ. Definition of neuronal circuitry controlling the activity of phrenic and abdominal motoneurons in the ferret using recombinant strains of pseudorabies virus. J Neurosci 20: 7446–7454, 2000.
Blessing WW, Nalivaiko E. Regional blood flow and nociceptive stimuli in rabbits: patterning by medullary raphe, not ventrolateral medulla. J Physiol 524: 279–292, 2000.
Brink TS, Hellman KM, Lambert AM, Mason P. Raphe magnus neurons help protect reactions to visceral pain from interruption by cutaneous pain. J Neurophysiol 96: 3423–3432, 2006.
Brink TS, Mason P. Role for raphe magnus neuronal responses in the behavioral reactions to colorectal distension. J Neurophysiol 92: 2302–2311, 2004.
Burgess SE, Gardell LR, Ossipov MH, Malan TP Jr, Vanderah TW, Lai J, Porreca F. Time-dependent descending facilitation from the rostral ventromedial medulla maintains, but does not initiate, neuropathic pain. J Neurosci 22: 5129–5136, 2002.
Cao Y, Fujito Y, Matsuyama K, Aoki M. Effects of electrical stimulation of the medullary raphe nuclei on respiratory movement in rats. J Comp Physiol 192: 497–505, 2006a.[CrossRef]
Cao Y, Matsuyama K, Fujito Y, Aoki M. Involvement of medullary GABAergic and serotonergic raphe neurons in respiratory control: electrophysiological and immunohistochemical studies in rats. Neurosci Res 56: 322–331, 2006b.[CrossRef][Web of Science][Medline]
Chiang CY, Gao B. The modification by systemic morphine of the responses of serotonergic and non-serotonergic neurons in nucleus raphe magnus to heating the tail. Pain 26: 245–257, 1986.[CrossRef][Web of Science][Medline]
Chiang CY, Pan ZZ. Differential responses of serotonergic and non-serotonergic neurons in nucleus raphe magnus to systemic morphine in rats. Brain Res 337: 146–150, 1985.[CrossRef][Web of Science][Medline]
Craig AD. A new view of pain as a homeostatic emotion. Trends Neurosci 26: 303–307, 2003.[CrossRef][Web of Science][Medline]
da Silva LF, Menescal-de-Oliveira L. Role of opioidergic and GABAergic neurotransmission of the nucleus raphe magnus in the modulation of tonic immobility in guinea pigs. Brain Res Bull 72: 25–31, 2007.[CrossRef][Web of Science][Medline]
Deakin JF, Dickenson AH, Dostrovsky JO. Morphine effects on rat raphe magnus neurons. J Physiol 267: 43P–45P, 1977.[Medline]
Eger EI 2nd. The pharmacology of isoflurane. Br J Anaesth 56 Suppl 1: 71S–99S, 1984.[Medline]
Fang FG, Haws CM, Drasner K, Williamson A, Fields HL. Opioid peptides (DAGO-enkephalin, dynorphin A(1-13), BAM 22P) microinjected into the rat brainstem: comparison of their antinociceptive effect and their effect on neuronal firing in the rostral ventromedial medulla. Brain Res 501: 116–128, 1989.[CrossRef][Web of Science][Medline]
Fields HL, Bry J, Hentall I, Zorman G. The activity of neurons in the rostral medulla of the rat during withdrawal from noxious heat. J Neurosci 3: 2545–2552, 1983a.[Abstract]
Fields HL, Heinricher MM, Mason P. Neurotransmitters in nociceptive modulatory circuits. Annu Rev Neurosci 14: 219–245, 1991.[CrossRef][Web of Science][Medline]
Fields HL, Vanegas H, Hentall ID, Zorman G. Evidence that disinhibition of brain stem neurons contributes to morphine analgesia. Nature 306: 684–686, 1983b.[CrossRef][Medline]
Foo H, Mason P. Bicuculline microinjection into the raphe magnus suppresses air puff-evoked awakenings in behaving rats. Soc Neurosci Abstract 247.1, 2000.
Foo H, Mason P. Brainstem modulation of pain during sleep and waking. Sleep Med Rev 7: 145–154, 2003a.[CrossRef][Web of Science][Medline]
Foo H, Mason P. Discharge of raphe magnus ON and OFF cells is predictive of the motor facilitation evoked by repeated laser stimulation. J Neurosci 23: 1933–1940, 2003b.
Gilbert AK, Franklin KB. The role of descending fibers from the rostral ventromedial medulla in opioid analgesia in rats. Eur J Pharmacol 449: 75–84, 2002.[CrossRef][Web of Science][Medline]
Grahn DA, Heller HC. Activity of most rostral ventromedial medulla neurons reflect EEG/EMG pattern changes. Am J Physiol Regulatory Integrative Comp Physiol 257: R1496–1505, 1989.
Hadziefendic S, Haxhiu MA. CNS innervation of vagal preganglionic neurons controlling peripheral airways: a transneuronal labeling study using pseudorabies virus. J Auton Nerv Syst 76: 135–145, 1999.[CrossRef][Web of Science][Medline]
Haxhiu MA, Erokwu BO, Cherniack NS. The brainstem network involved in coordination of inspiratory activity and cholinergic outflow to the airways. J Auton Nerv Syst 61: 155–161, 1996.[CrossRef][Web of Science][Medline]
Heinricher MM, Barbaro NM, Fields HL. Putative nociceptive modulating neurons in the rostral ventromedial medulla of the rat: firing of on- and off-cells is related to nociceptive responsiveness. Somatosens Mot Res 6: 427–439, 1989.[Web of Science][Medline]
Heinricher MM, Rosenfeld JP. Microinjection of morphine into nucleus reticularis paragigantocellularis of the rat: suppression of noxious-evoked activity of nucleus raphe magnus neurons. Brain Res 359: 388–391, 1985.[CrossRef][Web of Science][Medline]
Hurley RW, Hammond DL. The analgesic effects of supraspinal mu and delta opioid receptor agonists are potentiated during persistent inflammation. J Neurosci 20: 1249–1259, 2000.
Hurley RW, Hammond DL. Contribution of endogenous enkephalins to the enhanced analgesic effects of supraspinal mu opioid receptor agonists after inflammatory injury. J Neurosci 21: 2536–2545, 2001.
Jansen AS, Nguyen XV, Karpitskiy V, Mettenleiter TC, Loewy AD. Central command neurons of the sympathetic nervous system: basis of the fight-or-flight response. Science 270: 644–646, 1995.
Jinks SL, Carstens E, Antognini JF. Isoflurane differentially modulates medullary on and off neurons while suppressing hind-limb motor withdrawals. Anesthesiology 100: 1224–1234, 2004.[CrossRef][Web of Science][Medline]
Jones SL, Gebhart GF. Inhibition of spinal nociceptive transmission from the midbrain, pons and medulla in the rat: activation of descending inhibition by morphine, glutamate and electrical stimulation. Brain Res 460: 281–296, 1988.[CrossRef][Web of Science][Medline]
Kay DC. Human sleep during chronic morphine intoxication. Psychopharmacologia 44: 117–124, 1975.[CrossRef][Web of Science][Medline]
Kay DC, Pickworth WB, Neidert GL, Falcone D, Fishman PM, Othmer E. Opioid effects on computer-derived sleep and EEG parameters in nondependent human addicts. Sleep 2: 175–191, 1979.[Web of Science][Medline]
Kepler KL, Standifer KM, Paul D, Kest B, Pasternak GW, Bodnar RJ. Gender effects and central opioid analgesia. Pain 45: 87–94, 1991.[CrossRef][Web of Science][Medline]
Kerman IA, Enquist LW, Watson SJ, Yates BJ. Brainstem substrates of sympatho-motor circuitry identified using trans-synaptic tracing with pseudorabies virus recombinants. J Neurosci 23: 4657–4666, 2003.
Lalley PM. Responses of phrenic motoneurones of the cat to stimulation of medullary raphe nuclei. J Physiol 380: 349–371, 1986.
Leung CG, Mason P. A physiological survey of medullary raphe and magnocellular reticular neurons in the anesthetized rat. J Neurophysiol 80: 1630–1646, 1998.
Leung CG, Mason P. Physiological properties of raphe magnus neurons during sleep and waking. J Neurophysiol 81: 584–595, 1999.
Li YW, Bayliss DA. Electrophysical properties, synaptic transmission and neuromodulation in serotonergic caudal raphe neurons. Clin Exp Pharmacol Physiol 25: 468–473, 1998.[Web of Science][Medline]
Martin G, Montagne-Clavel J, Oliveras JL. Involvement of ventromedial medulla "multimodal, multireceptive" neurons in opiate spinal descending control system: a single-unit study of the effect of morphine in the awake, freely moving rat. J Neurosci 12: 1511–1522, 1992.[Abstract]
Mason P. Physiological identification of pontomedullary serotonergic neurons in the rat. J Neurophysiol 77: 1087–1098, 1997.
Mason P. Contributions of the medullary raphe and ventromedial reticular region to pain modulation and other homeostatic functions. Annu Rev Neurosci 24: 737–777, 2001.[CrossRef][Web of Science][Medline]
Mason P. Ventromedial medulla: pain modulation and beyond. J Comp Neurol 493: 2–8, 2005.[CrossRef][Web of Science][Medline]
Mason P, Escobedo I, Burgin C, Bergan J, Lee JH, Last EJ, Holub AL. Nociceptive responsiveness during slow-wave sleep and waking in the rat. Sleep 24: 32–38, 2001.[Web of Science][Medline]
Mason P, Strassman A, Maciewicz R. Intracellular responses of raphe magnus neurons during the jaw-opening reflex evoked by tooth pulp stimulation. Brain Res 379: 232–241, 1986.[CrossRef][Web of Science][Medline]
Meng ID, Manning BH, Martin WJ, Fields HL. An analgesia circuit activated by cannabinoids. Nature 395: 381–383, 1998.[CrossRef][Medline]
Mitchell JM, Lowe D, Fields HL. The contribution of the rostral ventromedial medulla to the antinociceptive effects of systemic morphine in restrained and unrestrained rats. Neuroscience 87: 123–133, 1998.[CrossRef][Web of Science][Medline]
Mogil JS. The genetic mediation of individual differences in sensitivity to pain and its inhibition. Proc Natl Acad Sci 96: 7744–7751, 1999.
Mogil JS, Wilson SG. Nociceptive and morphine antinociceptive sensitivity of 129 and C57BL/6 inbred mouse strains: implications for transgenic knock-out studies. Eur J Pain 1: 293–297, 1997.[CrossRef][Medline]
Morgan MM, Whitney PK. Immobility accompanies the antinociception mediated by the rostral ventromedial medulla of the rat. Brain Res 872: 276–281, 2000.[CrossRef][Web of Science][Medline]
Morrison SF, Sved AF, Passerin AM. GABA-mediated inhibition of raphe pallidus neurons regulates sympathetic outflow to brown adipose tissue. Am J Physiol 276: R290–297, 1999.[Web of Science][Medline]
Nadelhaft I, Vera PL. Neurons in the rat brain and spinal cord labeled after pseudorabies virus injected into the external urethral sphincter. J Comp Neurol 375: 502–517, 1996.[CrossRef][Web of Science][Medline]
Nadelhaft I, Vera PL. Separate urinary bladder and external urethral sphincter neurons in the central nervous system of the rat: simultaneous labeling with two immunohistochemically distinguishable pseudorabies viruses. Brain Res 903: 33–44, 2001.[CrossRef][Web of Science][Medline]
Nakamura K, Matsumura K, Hubschle T, Nakamura Y, Hioki H, Fujiyama F, Boldogkoi Z, Konig M, Thiel HJ, Gerstberger R, Kobayashi S, Kaneko T. Identification of sympathetic premotor neurons in medullary raphe regions mediating fever and other thermoregulatory functions. J Neurosci 24: 5370–5380, 2004.
Nakamura K, Matsumura K, Kobayashi S, Kaneko T. Sympathetic premotor neurons mediating thermoregulatory functions. Neurosci Res 51: 1–8, 2005.[CrossRef][Web of Science][Medline]
Nason MW Jr, Mason P. Modulation of sympathetic and somatomotor function by the ventromedial medulla. J Neurophysiol 92: 510–522, 2004.
Nason MW Jr, Mason P. Medullary raphe neurons facilitate brown adipose tissue activation. J Neurosci 26: 1190–1198, 2006.
Oliveras JL, Redjemi F, Guilbaud G, Besson JM. Analgesia induced by electrical stimulation of the inferior centralis nucleus of the raphe in the cat. Pain 1: 139–145, 1975.[CrossRef][Web of Science][Medline]
Parolaro D, Sala M, Crema G, Giagnoni G, Gori E. Cerebral sites of central action of dermorphin on intestinal motility in the rat. Peptides 6, Suppl 3: 149–153, 1985.
Porreca F, Burgess SE, Gardell LR, Vanderah TW, Malan TP Jr, Ossipov MH, Lappi DA, Lai J. Inhibition of neuropathic pain by selective ablation of brainstem medullary cells expressing the mu-opioid receptor. J Neurosci 21: 5281–5288, 2001.
Porreca F, Ossipov MH, Gebhart GF. Chronic pain and medullary descending facilitation. Trends Neurosci 25: 319–325, 2002.[CrossRef][Web of Science][Medline]
Randich A, Thurston CL, Ludwig PS, Robertson JD, Rasmussen C. Intravenous morphine-induced activation of vagal afferents: peripheral, spinal, and CNS substrates mediating inhibition of spinal nociception and cardiovascular responses. J Neurophysiol 68: 1027–1045, 1992.
Rathner JA, Owens NC, McAllen RM. Cold-activated raphe-spinal neurons in rats. J Physiol 535: 841–854, 2001.
Rechtschaffen A, Kales A. A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects. Washington, D.C.: US Government Printing Office, 1968.
Richerson GB. Serotonergic neurons as carbon dioxide sensors that maintain pH homeostasis. Nat Rev Neurosci 5: 449–461, 2004.[CrossRef][Web of Science][Medline]
Satoh M, Akaike A, Takagi H. Excitation by morphine and enkephalin of single neurons of nucleus reticularis paragigantocellularis in the rat: a probable mechanism of analgesic action of opioids. Brain Res 169: 406–410, 1979.[CrossRef][Web of Science][Medline]
Schnell C, Ulucan C, Ellrich J. Atypical on-, off- and NEUTRAL cells in the rostral ventromedial medulla oblongata in rat. Exp Brain Res 145: 64–75, 2002.[CrossRef][Web of Science][Medline]
Sessle BJ, Hu JW. Raphe-induced suppression of the jaw-opening reflex and single neurons in trigeminal subnucleus oralis, and influence of naloxone and subnucleus caudalis. Pain 10: 19–36, 1981.[CrossRef][Web of Science][Medline]
Shaw IR, Lavigne G, Mayer P, Choiniere M. Acute intravenous administration of morphine perturbs sleep architecture in healthy pain-free young adults: a preliminary study. Sleep 28: 677–682, 2005.[Web of Science][Medline]
Smith JE, Jansen AS, Gilbey MP, Loewy AD. CNS cell groups projecting to sympathetic outflow of tail artery: neural circuits involved in heat loss in the rat. Brain Res 786: 153–164, 1998.[CrossRef][Web of Science][Medline]
Sugino S, Kawamata M, Yamauchi M, Narimatsu E, Namiki A. Genetic differences in responses of rostral ventromedial medulla neurons induced by DAMGO, 
µ-opioid receptor agonist in mouse inbred strains. Soc Neurosci Abstr 248.11, 2006.
Szekely JI, Miglecz E, Bajusz S. Species differences in the relative analgesic potencies of some classical opiates and opioid peptides. Psychopharmacology 82: 400–402, 1984.[CrossRef][Medline]
Tanaka M, Owens NC, Nagashima K, Kanosue K, McAllen RM. Reflex activation of rat fusimotor neurons by body surface cooling, and its dependence on the medullary raphe. J Physiol 572: 569–583, 2006.
Ter Horst GJ, Hautvast RW, De Jongste MJ, Korf J. Neuroanatomy of cardiac activity-regulating circuitry: a transneuronal retrograde viral labelling study in the rat. Eur J Neurosci 8: 2029–2041, 1996.[CrossRef][Web of Science][Medline]
Toda K. Responses of raphe magnus neurons to systemic morphine in rats. Brain Res Bull 8: 101–103, 1982.[CrossRef][Web of Science][Medline]
Tyler CB, Advokat C. Investigation of "cross-tolerance" between systemic and intrathecal morphine in rats. Physiol Behav 37: 27–32, 1986.[CrossRef][Medline]
VanderHorst VG, Ulfhake B. The organization of the brainstem and spinal cord of the mouse: relationships between monoaminergic, cholinergic, and spinal projection systems. J Chem Neuroanat 31: 2–36, 2006.[CrossRef][Web of Science][Medline]
Wang W, Tiwari JK, Bradley SR, Zaykin RV, Richerson GB. Acidosis-stimulated neurons of the medullary raphe are serotonergic. J Neurophysiol 85: 2224–2235, 2001.
Wang YT, Wang N, Liu L. Studies on respiratory phase-switching effects of nucleus raphe magnus. Chicago Sci Bull 33: 1043–1048, 1988.
Yates BJ, Smail JA, Stocker SD, Card JP. Transneuronal tracing of neural pathways controlling activity of diaphragm motoneurons in the ferret. Neuroscience 90: 1501–1513, 1999.[CrossRef][Web of Science][Medline]
York EA, Baez MA, Mason P. Microinjection of DAMGO, a mu-opioid receptor agonist, into the ventromedial medulla delays volume-evoked micturition in anesthetized rats. Soc Neurosci Abstr 623.23, 2005.
Young EG, Watkins LR, Mayer DJ. Comparison of the effects of ventral medullary lesions on systemic and microinjection morphine analgesia. Brain Res 290: 119–129, 1984.[CrossRef][Web of Science][Medline]
This article has been cited by other articles:
|
|
 |
|
  K. M. Hellman, S. J. Mendelson, M. A. Mendez-Duarte, J. L. Russell, and P. Mason Opioid microinjection into raphe magnus modulates cardiorespiratory function in mice and rats Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2009; 297(5): R1400 - R1408. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
TOP
ABSTRACT
INTRODUCTION
), or saline into the RM (right, 
). A baseline period (b) preceded all microinjections (d), which were followed by systemic naloxone administration (n).
, left ordinate) and noxious heat-evoked responses (
, left ordinate) of murine ON cells are compared with mean withdrawal latency (—, right ordinate) before (base) and after multiple dosages (as labeled) of systemic (A) and central (B) morphine. The same variables are also illustrated after systemic naloxone administration (N) in A. The number of cells tested with each dose were as follows in A: 100 µg, n = 5; 500 µg, n = 20; 1 mg, n = 9; 2 mg, n = 7; naloxone, n = 18; and in B: 5 µg, n = 5; 10 µg, n = 7. Significant differences are marked: *P < 0.05 or **P < 0.01.
). The time points at which morphine and naloxone were injected are indicated by M and N, respectively. The scale bar at the bottom of B applies to the long records in A and B. The scale bar beneath the right histogram in B applies to all histograms.
